Speaker illustration

Ms Daniella Terenzi

St. Michael's Hospital, Toronto (Canada)

Daniella Terenzi graduated from the University of Western Ontario with a Bachelors in Health Science and an honors specialization in biology in 2016. She is currently a graduate student at the University of Toronto in the Institute of Medical Science. Her research interests include pro-vascular progenitor cells in patients with Type 2 Diabetes, the effect of antihyperglycemic agents on progenitor cell content and the reversal of regenerative cell exhaustion in Type 2 Diabetes. She has presented research at the European Molecular Biology Laboratory, the Canadian Cardiovascular Congress and the American Heart Association.

A novel role of SGLT2 inhibitors to increase circulating proangiogenic progenitor cells in patients with type 2 diabetes and cardiovascular disease: A sub-study of the EMPA-HEART CardioLink-6 Trial

Event: ESC Congress 2019

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Session: Insights into cardiac cell biology for repair and regeneration


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb